Arcturus Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $610 | $3,081 | $17,151 | $24,510 |
Gross Profit | -48 | 3,081 | 13,809 | 24,510 |
EBITDA | -26,306 | -20,139 | -12,685 | -8,397 |
EBIT | -26,964 | -20,821 | -13,448 | -9,176 |
Net Income | -26,964 | -29,079 | -13,448 | -9,180 |
Net Change In Cash | 610 | 3,081 | 17,151 | 24,510 |
Free Cash Flow | -19,441 | -16,364 | -17,332 | -5,755 |
Cash | 211,375 | 230,909 | 180,360 | 196,467 |
Basic Shares | 28,421 | 27,386 | 27,188 | 27,129 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $67,221 | $138,389 | $157,748 | $205,755 |
Gross Profit | 64,196 | 138,389 | 157,748 | 205,755 |
EBITDA | -62,758 | -77,401 | -24,165 | 15,172 |
EBIT | -65,783 | -80,945 | -27,122 | 13,645 |
Net Income | -65,783 | -80,941 | -29,725 | 9,349 |
Net Change In Cash | 67,221 | 138,389 | 157,748 | 205,755 |
Free Cash Flow | -74,271 | -60,395 | -21,000 | 24,267 |
Cash | 230,909 | 237,028 | 292,005 | 391,883 |
Basic Shares | 27,386 | 27,000 | 26,628 | 27,093 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.95 |
2025-12-31 | -$1.03 |
2025-09-30 | -$0.49 |
2025-06-30 | -$0.34 |